Patients now living a median 6.8 years after stage IV ALK+ lung cancer diagnosis Posted on 31/12/2018 by MilaStage IV ALK+ lung cancer patients treated at UCHealth University of Colorado Hospital between 2009 and 2017 had median overall survival of 6.8 years. Source: EurekaAlert, https://www.eurekalert.org